Feed

Earnings Highlights: Colgate, eBay, Goldman Sachs, Kimberley-Clark, Starbucks ...

Here are some highlights from this past week's earnings coverage on BloggingStocks:

  • Advanced Micro Devices Inc. (AMD) shares declined despite an earnings beat and a positive outlook
  • Bank of America Corp. (BAC) reported that its Q4 loss widened more than expected by Wall Street.
  • Capital One Financial Corp. (COF) reported better-than-expected earnings but shares declined.
  • Colgate-Palmolive Co. (CL) is seen as on-track to record double-digit earnings growth in 2010.
  • Cree Inc. (CREE) strong earnings and revenue growth sent shares to a new 52-week high.

Continue reading Earnings Highlights: Colgate, eBay, Goldman Sachs, Kimberley-Clark, Starbucks ...

The 10/10 Dividend Club

Looking for dividend-paying blue chip stocks? Chuck Carlson is a leading expert on dividend reinvestment plans.

In The DRIP Investor, he looks at the 10/10 Club -- stocks that have boosted their payouts by 10% a year for at least 10 years. He explains,"The table below features seven stocks that belong to the exclusive '10/10' club:

Continue reading The 10/10 Dividend Club

Colgate-Palmolive: Well-Positioned for the Recovery

Colgate-Palmolive Company (CL) is on-track to record double-digit earnings growth in 2010 and in the immediate year after, hence it goes without saying I'm reiterating my buy rating for the company's shares, first recommended on April 13, 2009, at a price of $58.49. If you bought CL in April 2009, you're up about 35%.

Lean, experienced Colgate-Palmolive has weathered the recession in good shape. Colgate, an assertive-defensive company, stayed one step ahead of the downturn -- closing about one-third of its factories, trimming excess marketing spending, and focusing on products in stronger-growth markets.

Continue reading Colgate-Palmolive: Well-Positioned for the Recovery

Comfort Zone Investing: Five Stocks for 2010

I'm going defensive this year. The stock market had a great run in 2009 with the Dow Jones Industrial Average and the S&P 500 index up more than 60%. It's hard to believe stocks can run too much higher. They can, of course, if earnings explode. But that seems like a drug-induced dream at this point, considering over 10% unemployment.

I also think interest rates will be higher next year, that the economy will improve somewhat, and that unemployment will go down but not by much. So I'm focusing on stock with these attributes:

Continue reading Comfort Zone Investing: Five Stocks for 2010

Serious Money: Fortune's 25 leaders, now 20

Yesterday I started a review of 25 companies that Fortune deemed most successful according to their peers in developing quality leadership. Today I review the remaining 20, searching to find the ones that might be worth investing in.

Price-to-book (from 11/27/09) was used as the first value screen. The theory being from a value investor's perspective that buying for a price at or near the break-up value of the company provides downside protection. Of course that is easier said than done.

Continue reading Serious Money: Fortune's 25 leaders, now 20

Serious Money: Fortune's 25 leaders among leaders

The recent issue of Fortune magazine discusses how the best of the best train, guide and nurture top managers to become the leaders that will propel their corporations successfully forward. They list the top 25 companies, which I have used as the basis of a new review to see how they would fair against common metric screens.

In the past few months, many articles have posited that large-cap stocks should excel in the coming year based on their lagging the market behind smaller, more volatile stocks flying out of the March lows. I do not believe this is universally true. Plenty of large-cap stocks did well, such as Anadarko Petroleum (APC), Apple (AAPL) and Google (GOOG), while many small caps went nowhere. Even among the large caps included in Fortune's "Leadership 25," some have doubled.

Continue reading Serious Money: Fortune's 25 leaders among leaders

Consumer goods to gain 5% next year, according to Fitch

The rest of the world is going to help U.S. consumer product manufacturers next year. Look for international growth to push the likes of Colgate-Palmolive (CL), Avon (AVP) and Clorox (CLX) higher in 2010, according to Fitch Ratings. In an interview with Reuters, a director gave the Fitch's outlook for consumer goods.

The household and personal care segments increased revenue every year from 2003 to 2008. So, 2009 was but a bump in the road. Even in a recession, you need toilet paper and shampoo, so expect the spending to come back.

Continue reading Consumer goods to gain 5% next year, according to Fitch

Cramer on BloggingStocks: Oil and the equity nirvana

The Street.com's Jim Cramer says that OPEC may take oil out of the equity-market equation and make stock-picking matter again.

If OPEC says it likes an oil price in the $75-78 range, as it said today, we could be looking at a nirvana moment for stocks. We know that any time oil bounces, the S&P 500 futures go up. Any time it goes down, the S&P futures go down. But if OPEC wants to keep it right here, we take oil out of the equation and make stock-picking matter again.

Right now, the Saudis are telling the big oil-shipping companies that they want to bring 1 million barrels a day into the market straight away to keep oil below $80. That can be used to overwhelm the speculators who are tying up as much as 20% of the oil fleet in the world to keep oil off the market and buoy its price. But they will not bring the oil to the market below $75.

Continue reading Cramer on BloggingStocks: Oil and the equity nirvana

Dividend growth trio: Aflac, Medtronic and Colgate-Palmolive

"One way to build an inflation hedge into your investment cash flows is to focus on stocks that are likely to boost their dividends on a regular basis," explains dividend specialist Chuck Carlson.

In his The DRIP Investor, which focuses on blue chip companies offering dividend reinvestment programs, he notes, "Since dividends are paid with cold cash, they can't be faked. Either you pay the dividend or you don't. They can't be some figment of accounting magic." Here, he looks at three favorite blue chips with strong dividend records.

Continue reading Dividend growth trio: Aflac, Medtronic and Colgate-Palmolive

Clorox starts its new year off right

Clorox (NYSE: CLX), a consumer-products business that counts Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) as related stocks, may have seen a sales drop of 1% in its fiscal first quarter, but that didn't stop it from posting a nice bottom-line growth rate. Clorox made $1.11 per share in Q1, and that represents a 23% increase. What a way to start a new corporate year!

According to Reuters, expectations were for 95 cents per share. That's a wonderful beat. Plus, sales volume went up 1%. Helping to drive things along was a healthy gross margin, as well as the dreaded H1N1 virus. Clorox has done well over the years associating its brand with sanitizing effectiveness, so when a pandemic rears its ugly head, the trademark is prepared to leverage such reputation to drive value.

Continue reading Clorox starts its new year off right

Bad September, good Q3 for consumer spending, what's next?

Consumer spending had its largest fall this year, thanks to the end of the "Cash for Clunkers" program. And, incomes were flat. No change to the money coming in and a drop in the cash going out translates to an impediment to economic recovery.

In September, consumer spending fell 0.5%, the first decline in five months and the worst in nine. Wages and salaries dropped 0.2%, effectively offsetting the 0.2% up-tick in August. The economy did grow in the third quarter of 2009, hinting that the worst recession in 70 years may be coming to a close, but the tough September suggests we still have some work in front of us.

Continue reading Bad September, good Q3 for consumer spending, what's next?

Colgate-Palmolive: One step ahead of the recession, one step ahead of the recovery

Lean, experienced Colgate-Palmolive (NYSE: CL) has weathered the recession in good shape, hence it goes without saying that I'm Reiterating my Buy rating for the company, first recommended on April 13, 2009 at a price of $58.49. If you bought in April, you're up 36%.

Colgate, an assertive-defensive play, stayed one step ahead of the downturn – closing about one-third of its factories, trimming excess marketing spending, and focusing on products in stronger-growth markets.

Continue reading Colgate-Palmolive: One step ahead of the recession, one step ahead of the recovery

Under new leadership, P&G begins to build a brighter future

As with the consumers to whom it sells, Procter & Gamble Co. (NYSE: PG) has weathered tough times in recent months. The Cincinnati company saw revenues fall and volumes squeezed (not unlike its trademark Charmin bath tissue) as recession-weary shoppers continued to rein-in expenses and begged off buying pricier goods.

Still, following a year in which the company faced one of the most difficult macroeconomic environments in decades, P&G surprised analysts Thursday by reporting fiscal first-quarter earnings of $3.31 billion, or $1.06 a share, compared with $3.35 billion, or $1.03 a share, a year earlier. Analysts polled by Zacks.com anticipated the company would earn just 97 cents a share.

Continue reading Under new leadership, P&G begins to build a brighter future

Analyst upgrades, downgrades and initiations: ANN, BBY, CBS, CL, MRVL, NOK, Q ...

Analyst upgrades:

  • FBR Capital upgraded Ann Taylor (NYSE: ANN) to Outperform from Market Perform to reflect a recovery in the missy sector and the company's product improvement. The firm raised its target on shares to $19 from $13.
  • Roth Capital upgraded Marvell Tech (NASDAQ: MRVL) to Buy from Hold based on product cycle strength in wireless and Ethernet, HDD share gains, and a return of PC growth. Target is $22.
  • Goldman upgraded Colgate (NYSE: CL) to Buy from Neutral citing valuation and expectations for a pick-up in unit growth. The firm raised its price target to $85 from $83. Note that Goldman downgraded Clorox to Neutral from Buy.
  • Cadbury (NYSE: CBY) was upgraded to Neutral from Underweight at HSBC.
  • Garmin (NASDAQ: GRMN) was upgraded to Buy from Underperform at BofA/Merrill.
  • Qwest (NYSE: Q) was upgraded to Market Weight from Underweight at Thomas Weisel.

Continue reading Analyst upgrades, downgrades and initiations: ANN, BBY, CBS, CL, MRVL, NOK, Q ...

Seven dividend elites: 100 years of dividends

"While companies have been cutting dividends at an historic pace over the last 24 months, the fact is that there are still quality companies with long histories of paying dividends that represent good long-term investments," says Chuck Carlson, a specialist in companies offering dividend reinvestment plans.

In his top-notch The DRIP Investor he says, "The seven stocks featured here have each been paying a dividend for over 100 years, have raised their dividend annually for at least the last quarter century and offer direct-purchase plans.

Continue reading Seven dividend elites: 100 years of dividends

Next Page »

Symbol Lookup
IndexesChangePrice
DJIA+150.2510,058.64
NASDAQ+24.822,150.87
S&P 500+13.781,070.52

Last updated: February 09, 2010: 09:15 PM

Hot Stocks

DailyFinance Headlines

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

CNNMoney Headlines

More CNNMoney.com

Financial Times Headlines

More Financial Times

CNBC Headlines

More CNBC.com

SmartMoney Headlines

More SmartMoney

Fox Business Headlines

More Fox Business

Engadget Headlines

More Engadget